Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Kuczia (Krakow, Poland), L. Mastalerz (Krakow, Poland), D. Potaczek (Marburg, Germany), A. Cybulska (Krakow, Poland), L. Zareba (Rzeszow, Poland), S. Bazan-Socha (Krakow, Poland), A. Undas (Krakow, Poland). Increased activity of lipoprotein-associated phospholipase A2 in non-severe asthma. 3342

Member's Comments

No comment yet.

Related content which might interest you: Regulation and overexpression of 85-kDa cytosolic phospholipase A2 in asthma Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Differential actions of phosphatidyinositol 3-kinase inhibitors on respiratory burst and leukotriene C4 generation in PAF-stimulated human eosinophils Source: Eur Respir J 2003; 22: Suppl. 45, 547s Year: 2003 Lipoprotein-associated phospholipase A2 levels as a predictor of cardiovascular risks in patients with COPD and obstructive sleep apnea Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 An association study between thromboxane A2 receptor gene T924C polymorphism and the severity of asthma in Chinese children Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001 Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice Source: Eur Respir J 2010; 36: 1120-1130 Year: 2010 Novel cytosolic phospholipase A2 (cPLA2) promoter single nucleotide polymorphisms Source: Eur Respir J 2006; 28: Suppl. 50, 229s Year: 2006 Anti-inflammatory lipoxin A4 is diminished in acute, severe exacerbations of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002 Imbalance between leukoprotease inhibitor levels and neutrophils in BAL from smokers with chronic bronchitis and recurrent exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 Relationship between serum and sol secretory leukoprotease inhibitor (SLPI) during exacerbations of chronic bronchitis Source: Eur Respir J 2006; 28: Suppl. 50, 796s Year: 2006 Elevation of neutrophil collagenase (MMP-8) and elastase during COPD exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation Source: Eur Respir J 2003; 22: 739-742 Year: 2003 Neutrophil elastase in severe COPD and asthma exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 36s Year: 2006 Increased plasma fibrinogen could predict frequent exacerbations in asthma Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Assessment of in vivo 5-lipoxygenase (5-LO) activity in nonatopic and atopic subjects with or without asthma: effects of treatment with the 5-LO inhibitor zileuton Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003 Dual inhibition of thromboxane synthase and 5-lipoxygenase, potentially significant mechanism for the treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 264s Year: 2001 A novel mechanism for upregulation of β2-integrin and adhesion of eosinophils by secretory group V phospholipase A2 independent of cytosolic phospholipase A2 activation Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Promoter polymorphisms of cysteinyl leukotriene type 1 receptor in patients with severe asthma Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury Source: Eur Respir J 2003; 21: 1040-1045 Year: 2003 Cytosolic phospholipase A2 promoter repeats polymorphisms regulate its transcriptional activity Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005